Diabetes Research and Clinical Practice
Volume 90, Issue 1 , Pages 40-44 , October 2010

The impact of health insurance coverage on pediatric diabetes management

  • Kupper A. Wintergerst

      Affiliations

    • Department of Pediatrics, Division of Endocrinology, School of Medicine, University of Louisville, 571 South Floyd Street, Louisville, KY 40202, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 502 852 4347; fax: +1 502 852 4189.
    • ,
  • Krystal M. Hinkle

      Affiliations

    • Department of Pediatrics, Division of Endocrinology, School of Medicine, University of Louisville, 571 South Floyd Street, Louisville, KY 40202, USA
    • ,
  • Christopher N. Barnes

      Affiliations

    • Department of Bioinformatics and Biostatistics, School of Public Health and Information Sciences, University of Louisville, Louisville, KY 40202, USA
    • ,
  • Adetokunbo O. Omoruyi

      Affiliations

    • Department of Pediatrics, Division of Endocrinology, School of Medicine, University of Louisville, 571 South Floyd Street, Louisville, KY 40202, USA
    • ,
  • Michael B. Foster

      Affiliations

    • Department of Pediatrics, Division of Endocrinology, School of Medicine, University of Louisville, 571 South Floyd Street, Louisville, KY 40202, USA

Received 22 March 2009 ,Revised 6 May 2010 ,Accepted 10 June 2010.

References 

  1. Centers for Disease Control and Prevention . National diabetes fact sheet: General information and national estimates on diabetes in the United States, 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2008;
  2. Moore DJ, Gregory JM, Kumah-Crystal YA, Simmons JH. Mitigating micro- and macro-vascular complications of diabetes beginning in adolescence. Vasc Health Risk Manag. 2009;5:1015–1031
  3. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328(23):1676–1685
  4. Nathan DM, Zinman B, Cleary PA, Backlund JY, Genuth S, Miller R, et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years’ duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983–2005). Arch Intern Med. 2009;169(14):1307–1316
  5. Bogdanovic R. Diabetic nephropathy in children and adolescents. Pediatr Nephrol. 2008;23(4):507–525
  6. Lin J, Glynn RJ, Rifai N, Manson JE, Ridker PM, Nathan DM, et al. Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial. Diabetes Care. 2008;31(12):2338–2343
  7. The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986
  8. Graff MR, McClanahan MA. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther. 1998;20(3):486–496
  9. Haller MJ, Stalvey MS, Silverstein JH. Predictors of control of diabetes: monitoring may be the key. J Pediatr. 2004;144(5):660–661
  10. Schiffrin A, Belmonte M. Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections. Diabetes Care. 1982;5(5):479–484
  11. Shone LP, Dick AW, Klein JD, Zwanziger J, Szilagyi PG. Reduction in racial and ethnic disparities after enrollment in the State Children's Health Insurance Program. Pediatrics. 2005;115(6):e697–705
  12. Shone LP, Szilagyi PG. The State Children's Health Insurance Program. Curr Opin Pediatr. 2005;17(6):764–772
  13. Thompson JW, Ryan KW, Pinidiya SD, Bost JE. Quality of care for children in commercial and Medicaid managed care. JAMA. 2003;290(11):1486–1493
  14. Simpson L, Owens PL, Zodet MW, Chevarley FM, Dougherty D, Elixhauser A, et al. Health care for children and youth in the United States: annual report on patterns of coverage, utilization, quality, and expenditures by income. Ambul Pediatr. 2005;5(1):6–44
  15. Skinner AC, Mayer ML. Effects of insurance status on children's access to specialty care: a systematic review of the literature. BMC Health Serv Res. 2007;7:194
  16. Todd J, Armon C, Griggs A, Poole S, Berman S. Increased rates of morbidity, mortality, and charges for hospitalized children with public or no health insurance as compared with children with private insurance in Colorado and the United States. Pediatrics. 2006;118(2):577–585
  17. White NH, Sun W, Cleary PA, Danis RP, Davis MD, Hainsworth DP, et al. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol. 2008;126(12):1707–1715
  18. Nguyen TM, Mason KJ, Sanders CG, Yazdani P, Heptulla RA. Targeting blood glucose management in school improves glycemic control in children with poorly controlled type 1 diabetes mellitus. J Pediatr. 2008;153(4):575–578
  19. Korytkowski M, Bell D, Jacobsen C, Suwannasari R. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther. 2003;25(11):2836–2848
  20. Korytkowski M, Niskanen L, Asakura T. FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther. 2005;27(Suppl. B):S89–100
  21. Pfutzner A, Asakura T, Sommavilla B, Lee W. Insulin delivery with FlexPen: dose accuracy, patient preference and adherence. Expert Opin Drug Deliv. 2008;5(8):915–925

PII: S0168-8227(10)00314-1

doi: 10.1016/j.diabres.2010.06.013

Diabetes Research and Clinical Practice
Volume 90, Issue 1 , Pages 40-44 , October 2010

Article Tools

* Image Usage & Resolution